Related Experiment Video
Updated: Aug 25, 2026
Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
Models for angiogenesis in gliomas
Roland H Goldbrunner1, Martin Bendszus, Jörg-Christian Tonn
1Department of Neurosurgery, Grosshadern Hospital, Ludwig-Maximilians, University of Munich, 81377 Munich, Germany.
Abstract:
During the last decades a lot of attention has been focussed on mechanisms of glioma vascularization, particularly in terms of investigating vascular growth factors and receptors. Recently, these efforts resulted in various approaches for antiangiogenic treatment strategies using in vitro cell culture systems as well as experimental orthotopic and non-orthotopic brain tumors. These basic science and preclinical trials need an assortment of models, which should allow investigating a variety of questions. Several objectives concerning basic endothelial cell (EC) characteristics can adequately be studied in vitro using EC monolayer assays. Three-dimensional spheroid techniques respect the more complex cell-cell and cell-environment interplay within a 3-dimensional culture. Recent advances in molecular genetic techniques offer a wide access to the genome of EC. Using these micro array or chip methods differences between micro- and macromolecular EC as well as variations within the gene pool of different organ specific EC can be assessed. To optimize the imitation of the crucial interaction of human gliomas with host endothelial cells, immunological cells and extracellular matrix, animal models are mandatory. An essential rule is to utilize an orthotopic model, since tumor-host-interaction is organ specific. To avoid alloimmunogenic responses, it is desirable to use weak or non-immunogenic glioma grafts, which is best accomplished in a syngeneic model. However, since rat gliomas poorly resemble human glioma growth patterns, human glioma xenografting into immunocompromized animals should be considered. In vivo-monitoring techniques like videoscopy via a cranial window or magnetic resonance imaging (MRI) allow for functional studies and improve the validity of the model employed. Finally, it is essentially to recognize the limitations of each model considered and to select that model which seems to be most appropriate for the objectives to be investigated.
Insights
Researchers explored various models for studying glioma vascularization and anti-angiogenic therapies. Selecting the appropriate model, from in vitro assays to in vivo animal studies, is crucial for valid research outcomes.
Area of Science:
- Oncology
- Vascular Biology
- Biomedical Engineering
Background:
- Significant research has focused on glioma vascularization mechanisms, including growth factors and receptors.
- Anti-angiogenic treatment strategies for gliomas are being developed using various in vitro and in vivo models.
- Preclinical trials necessitate a diverse range of models to address complex research questions.
Purpose of the Study:
- To review and discuss the suitability of different experimental models for studying glioma vascularization and anti-angiogenic therapies.
- To highlight the importance of selecting appropriate models that mimic crucial tumor-host interactions.
- To emphasize the need for understanding model limitations for effective research design.
Main Methods:
- In vitro endothelial cell (EC) monolayer assays for basic EC characteristics.
- Three-dimensional spheroid techniques for cell-cell and cell-environment interactions.
- Molecular genetic techniques (microarray/chip) for assessing EC gene expression.
- Animal models, including orthotopic and syngeneic models, for tumor-host interactions.
- Human glioma xenografting into immunocompromised animals.
- In vivo monitoring techniques (videoscopy, MRI) for functional studies.
Main Results:
- In vitro models are suitable for basic EC characteristics, while 3D spheroids offer more complex interactions.
- Molecular techniques allow detailed analysis of EC gene expression.
- Orthotopic animal models are essential for studying organ-specific tumor-host interactions.
- Syngeneic models minimize allo-immunogenic responses, but rat gliomas may not accurately reflect human growth.
- Human glioma xenografts in immunocompromised animals are a viable alternative.
- In vivo monitoring enhances the validity and functional assessment of experimental models.
Conclusions:
- A variety of models exist for studying glioma vascularization, each with specific strengths and limitations.
- The choice of model should be tailored to the specific research objectives, considering factors like tumor-host interaction and immunogenicity.
- Recognizing the limitations of each model is paramount for the validity and successful application of research findings in anti-angiogenic therapy development.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
04:30A Photopolymerizable Hyaluronic Acid-Collagen Model of the Invasive Glioma Microenvironment with Interstitial Flow
Published on: October 18, 2024
Related Concept Videos
01:10Mechanism of Angiogenesis
01:24Regulation of Angiogenesis and Blood Supply